Site icon fundsforNGOs

CFPs: Breakthrough Solutions and Cost-Disruptive Innovations for Screening and Diagnosis (India)

UK-Israel Eureka Bilateral Collaborative R&D: Round 2

Deadline: 01-Jul-2026

The Grand Challenges India (GCI–BIRAC) has launched an open call to support indigenous innovations in infectious disease screening and diagnostics across India. The program funds high-impact diagnostic solutions for tuberculosis, emerging pathogens, syndromic panels, and enteric diseases. Funding ranges from INR 50 lakh to INR 2 crore depending on project stage, with durations up to 18 months.

Grand Challenges India (GCI–BIRAC) Diagnostics Innovation Call Overview

The initiative aims to strengthen India’s capacity for developing affordable, scalable, and accessible diagnostic technologies for priority infectious diseases. It supports early-stage research and product development focused on transforming how diseases are detected and managed at or near the point of care.

The program encourages high-risk, high-reward innovation that can lead to practical diagnostic solutions for widespread use in healthcare systems.

Key Focus Areas

The call prioritizes innovation in infectious disease diagnostics, including:

It particularly emphasizes:

Program Objectives and Support

The program aims to:

Support provided includes:

Funding Structure

Two categories of funding are available:

Eligibility Criteria

Eligible applicants include:

The program strongly encourages:

Expected Impact

The initiative is designed to:

Conclusion

The Grand Challenges India and BIRAC initiative provides a structured funding opportunity to accelerate innovation in infectious disease diagnostics. By supporting scalable, low-cost, and high-impact technologies, the program aims to improve early detection and strengthen healthcare response systems across India.

For more information, visit BIRAC.

Exit mobile version